CCND3
HGNC:1585 · SaudiVarKB evidence summary derived from retained literature mentions.
4Gene mentions
4Publications
0Linked variants
1Associated phenotypes
Associated phenotypes
Co-mentioned in CCND3 publications| Phenotype | Identifier | Articles | Mentions |
|---|---|---|---|
| colorectal cancer | — | 4 | 4 |
Linked variants
Variants normalized to CCND3| Variant | HGVS / rsID | Articles | Mentions |
|---|
No normalized variants are linked to this gene.
Population context
Reported in the same publications| Country / region | Group | Cohort | Articles |
|---|
No structured population context is available.
Supporting publications
4 records- 2026Irisin Potentiates 5-fluorouracil Cytotoxicity in HT-29 Colon Cancer Cells through Enhanced Apoptosis and Transcriptional Modulation of Adenosine Monophosphate-activated Protein Kinase/Mammalian Target of Rapamycin Signaling.International journal of applied & basic medical researchPubMed ↗
- 2025Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation.Journal of the Egyptian National Cancer InstitutePubMed ↗
- 2025Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets.Discover oncologyPubMed ↗
- 2023Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.BioFactors (Oxford, England)PubMed ↗